Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A study of 8,000 people showed: People who stayed on the medicine lost about 12% in 1 year People who stopped early lost only about 3.6% Why the difference
BensonJCMaraisMDFlaniganPMBydonMGianniniCSpinnerRJet alMalignant melanotic nerve sheath tumor
Do not take more than one tablet per day
It's used in research and wellness settings for comprehensive support of healing, inflammation, and tissue repair
If the remaining Phase 3 readouts hold and the FDA filing proceeds on the projected late- 2026 timeline, retatrutide is positioned to arrive as the unambiguous class leader and the first obesity drug whose efficacy curve starts to genuinely overlap with bariatric surgery
US$ 21.45
US$ 22.39
US$ 23.95
